Study Details
A Phase III, Randomized, Double-blind, Double-dummy, Multi-center Clinical Study to Observe the Efficacy and Safety of Febuxostat Compared with Allopurinol in Subjects with Hyperuricemia (Including Gout)
Clinicaltrials.gov ID
N/A
Astellas Study ID
TMX-67-CN-001
EudraCT ID
N/A
Condition
Elevated Uric Acid
Phase
Phase 3
Age
18 Years - 85 Years
Sex
Female & Male
Product
febuxostat
Type
Interventional
Trial Dates
Apr 2013 - Jan 2015
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
599
A Phase III, Randomized, Double-blind, Double-dummy, Multi-center Clinical Study to Observe the Efficacy and Safety of Febuxostat Compared with Allopurinol in Subjects with Hyperuricemia (Including Gout)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Phase III, Randomized, Double-blind, Double-dummy, Multi-center Clinical Study to Observe the Efficacy and Safety of Febuxostat Compared with Allopurinol in Subjects with Hyperuricemia (Including Gout)? Contact us by filling our your information to the right and we’ll respond to you.